2024
Hepatitis C and its treatment in patients with psoriasis: a propensity-matched case-control study
Zhu H, Shaw V, Cohen J. Hepatitis C and its treatment in patients with psoriasis: a propensity-matched case-control study. Archives Of Dermatological Research 2024, 316: 580. PMID: 39207533, DOI: 10.1007/s00403-024-03340-2.Peer-Reviewed Original ResearchAssociation between psoriasis and obsessive-compulsive disorder: a case-control study in the All of Us research program
Craver A, Chen G, Fan R, Levey D, Cohen J. Association between psoriasis and obsessive-compulsive disorder: a case-control study in the All of Us research program. Archives Of Dermatological Research 2024, 316: 280. PMID: 38796663, DOI: 10.1007/s00403-024-03112-y.Peer-Reviewed Original ResearchBiologics for Psoriasis
Wride A, Chen G, Spaulding S, Tkachenko E, Cohen J. Biologics for Psoriasis. Dermatologic Clinics 2024, 42: 339-355. PMID: 38796266, DOI: 10.1016/j.det.2024.02.001.Peer-Reviewed Original ResearchConceptsIL-23IL-17ALong-term risk-benefit profileTNF-aLong-term adverse eventsIL-23 inhibitorsTumor necrosis factor-alphaP19 subunit of IL-23Risk-benefit profileSubunit of IL-23TNF-a inhibitorsTreatment of psoriasisNecrosis factor-alphaHigher Psoriasis AreaRates of short-termIL-12/23Psoriasis AreaIL-17FAdverse eventsIL-12IL-17Factor-alphaP19 subunitInjectable biologicsP40 subunitPsoriasis associated with inflammatory bowel disease: a cross‐sectional analysis in the NIH All of Us Research Program
Joel M, Wride A, Cohen J. Psoriasis associated with inflammatory bowel disease: a cross‐sectional analysis in the NIH All of Us Research Program. International Journal Of Dermatology 2024, 63: e82-e83. PMID: 38204174, PMCID: PMC10922412, DOI: 10.1111/ijd.17015.Peer-Reviewed Original Research
2023
Association of psoriasis and systemic lupus erythematosus and mediation effects of tumor necrosis factor-α inhibitors: A cross-sectional study in the All of Us Research Program
Chen G, Hong S, Ramachandran S, Gehlhausen J, Cohen J. Association of psoriasis and systemic lupus erythematosus and mediation effects of tumor necrosis factor-α inhibitors: A cross-sectional study in the All of Us Research Program. Journal Of The American Academy Of Dermatology 2023, 90: 184-187. PMID: 37734665, DOI: 10.1016/j.jaad.2023.09.028.Peer-Reviewed Original ResearchAssessment of Treatment-Relevant Immune Biomarkers in Psoriasis and Atopic Dermatitis: Toward Personalized Medicine in Dermatology
Mortlock R, Ma E, Cohen J, Damsky W. Assessment of Treatment-Relevant Immune Biomarkers in Psoriasis and Atopic Dermatitis: Toward Personalized Medicine in Dermatology. Journal Of Investigative Dermatology 2023, 143: 1412-1422. PMID: 37341663, PMCID: PMC10830170, DOI: 10.1016/j.jid.2023.04.005.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsAtopic dermatitisSkin diseasesInflammatory skin diseaseInflammatory skin conditionImmunologic biomarkersImmune biomarkersPersonalized medicineInflammatory dermatosesImmunologic approachesTherapy selectionSkin conditionsSingle-cell RNA sequencingMolecular profilingBiomarkersTissue stainingPsoriasisDermatitisDiseaseDermatologyRNA sequencingMedicineCurettageDermatosesTherapyPersonalized classificationAssociation between psoriasis and celiac disease: A cross-sectional study in the All of Us Research Program
Joel M, Fan R, Cohen J. Association between psoriasis and celiac disease: A cross-sectional study in the All of Us Research Program. Journal Of The American Academy Of Dermatology 2023, 88: 1386-1388. PMID: 36775104, DOI: 10.1016/j.jaad.2023.02.004.Peer-Reviewed Original ResearchPsoriasis associated with asthma and allergic rhinitis: a US-based cross-sectional study using the All of US Research Program
Joel M, Fan R, Damsky W, Cohen J. Psoriasis associated with asthma and allergic rhinitis: a US-based cross-sectional study using the All of US Research Program. Archives Of Dermatological Research 2023, 315: 1823-1826. PMID: 36707438, DOI: 10.1007/s00403-023-02539-z.Peer-Reviewed Original ResearchConceptsAllergic rhinitisUS adultsUs Research ProgramCommon chronic inflammatory diseaseMultivariable logistic regression modelNationwide longitudinal cohortImmunopathogenesis of psoriasisBody mass indexChronic inflammatory diseaseCases of asthmaCross-sectional studyLogistic regression modelsMultivariable analysisSmoking statusMass indexInflammatory pathwaysSubgroup analysisInflammatory diseasesLongitudinal cohortHigh prevalenceAsthmaPsoriasisPotential associationDiverse cohortSociodemographic variablesThe effect of baseline eczema or psoriasis on the morphology of cutaneous immune-related adverse events due to immune checkpoint inhibitor therapy
Belzer A, Mortlock R, Pach J, Cohen J, Leventhal J. The effect of baseline eczema or psoriasis on the morphology of cutaneous immune-related adverse events due to immune checkpoint inhibitor therapy. Journal Of The American Academy Of Dermatology 2023, 88: 1198-1200. PMID: 36634749, PMCID: PMC10121758, DOI: 10.1016/j.jaad.2023.01.002.Peer-Reviewed Original Research
2022
Lichen sclerosus among women with psoriasis: A cross-sectional study in the All of Us research program
Fan R, Leasure A, Little A, Cohen J. Lichen sclerosus among women with psoriasis: A cross-sectional study in the All of Us research program. Journal Of The American Academy Of Dermatology 2022, 88: 1175-1177. PMID: 36529377, DOI: 10.1016/j.jaad.2022.12.012.Peer-Reviewed Original ResearchThe association of anxiety with granuloma annulare: a case–control study of the National Institutes of Health ‘All of Us’ research programme
Belzer A, Leasure A, Damsky W, Cohen J. The association of anxiety with granuloma annulare: a case–control study of the National Institutes of Health ‘All of Us’ research programme. British Journal Of Dermatology 2022, 188: 558-560. PMID: 36715356, DOI: 10.1093/bjd/ljac114.Peer-Reviewed Original ResearchConceptsCase-control studyGranuloma annulareMental health conditionsInflammatory dermatosesHealth conditionsInflammatory skin diseaseImprovement of depressionAssociation of anxietyPost-traumatic stress disorderOpioid dependenceAutoimmune disordersProinflammatory cytokinesBody of evidenceDear EditorSkin diseasesSignificant associationDermatosesStress disorderNational InstituteAnnulareAssociationDisordersDepressionAnxietyDyslipidaemiaAssociation of sarcoidosis with psoriasis: a cross-sectional study in the All of Us research program
Murphy M, Leasure A, Damsky W, Cohen J. Association of sarcoidosis with psoriasis: a cross-sectional study in the All of Us research program. Archives Of Dermatological Research 2022, 315: 1439-1441. PMID: 36436011, DOI: 10.1007/s00403-022-02488-z.Peer-Reviewed Original ResearchConceptsCross-sectional studyMatched cross-sectional studyAssociation of sarcoidosisCoexistence of sarcoidosisCommon genetic susceptibilitySimilar immunopathogenesisCardiopulmonary symptomsPsoriasis patientsInflammatory skinMultivariable analysisSystemic diseasePsoriasis casesProgram databaseImmune responseSarcoidosisPsoriasisUs Research ProgramPotential associationGenetic susceptibilityDiseaseImmunopathogenesisAssociationSame individualFurther researchTh1Vaccination Recommendations for Psoriasis and Atopic Dermatitis Patients on Biologic Therapy: A Practical Guide.
Fan R, Cohen JM. Vaccination Recommendations for Psoriasis and Atopic Dermatitis Patients on Biologic Therapy: A Practical Guide. The Yale Journal Of Biology And Medicine 2022, 95: 249-255. PMID: 35782480, PMCID: PMC9235258.Peer-Reviewed Original ResearchConceptsAtopic dermatitis patientsBiologic therapyVaccination recommendationsDermatitis patientsTreatment of psoriasisNovel biologic therapiesIL-17IL-23Atopic dermatitisIL-12/23Vaccine administrationClinical dataHealthcare providersAvailable guidelinesPsoriasisTherapyUnique considerationsPatientsPractical guideVaccinationDermatitisTNFαInfectionDermatologistsAdministrationProvider-level prescription patterns among dermatologists utilizing injectable biologics in psoriasis treatment
Ugwu N, Cheraghlou S, Feng H, Cohen JM. Provider-level prescription patterns among dermatologists utilizing injectable biologics in psoriasis treatment. Journal Of Dermatological Treatment 2022, 33: 2876-2877. PMID: 35509155, DOI: 10.1080/09546634.2022.2071820.Peer-Reviewed Original Research
2021
Comment on: Development of psoriasis during treatment with dupilumab: A systematic review
Cohen JM, Damsky W. Comment on: Development of psoriasis during treatment with dupilumab: A systematic review. Journal Of The American Academy Of Dermatology 2021, 86: e115. PMID: 34311044, DOI: 10.1016/j.jaad.2021.06.893.Peer-Reviewed Original ResearchDupilumab‐induced phenotype switch from atopic dermatitis to psoriasis is characterized by de novo interleukin‐17A expression: a case report
Mirza F, Wang A, Ramachandran S, Damsky W, Cohen J. Dupilumab‐induced phenotype switch from atopic dermatitis to psoriasis is characterized by de novo interleukin‐17A expression: a case report. British Journal Of Dermatology 2021, 185: 432-434. PMID: 33730377, DOI: 10.1111/bjd.20064.Peer-Reviewed Original ResearchMeSH KeywordsAntibodies, Monoclonal, HumanizedDermatitis, AtopicHumansInterleukin-17PhenotypePsoriasisConceptsInterleukin-17A expression
2020
Paradoxical eruptions to targeted therapies in dermatology: A systematic review and analysis
Murphy MJ, Cohen JM, Vesely MD, Damsky W. Paradoxical eruptions to targeted therapies in dermatology: A systematic review and analysis. Journal Of The American Academy Of Dermatology 2020, 86: 1080-1091. PMID: 33307146, DOI: 10.1016/j.jaad.2020.12.010.Peer-Reviewed Original ResearchConceptsParadoxical reactionSystematic reviewNecrosis factor α inhibitorsTumor necrosis factor αSpectrum of manifestationsNecrosis factor αAntibody-based therapiesInterleukin-12/23IL-23IL-12/23Clinical featuresCutaneous reactionsEczematous eruptionInflammatory disordersProinflammatory cytokinesΑ inhibitorsRetrospective analysisIL-4RαFactor αPotential mechanismsDermatologyTherapyInhibitorsAntibodiesReaction patternsSystemic treatment of psoriasis and psoriatic arthritis in the United States: a cross-sectional study
Steuer AB, Wang JF, Feng H, Cohen JM. Systemic treatment of psoriasis and psoriatic arthritis in the United States: a cross-sectional study. Journal Of Dermatological Treatment 2020, 33: 1193-1194. PMID: 32715842, DOI: 10.1080/09546634.2020.1795059.Peer-Reviewed Original ResearchPsoriasis With Eczematous Features: A Retrospective Clinicopathologic Study.
Noorily AR, Criscito MC, Cohen JM, Brinster NK. Psoriasis With Eczematous Features: A Retrospective Clinicopathologic Study. American Journal Of Dermatopathology 2020, 43: 112-118. PMID: 32618707, DOI: 10.1097/dad.0000000000001711.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, CutaneousAdministration, OralAdultAgedAged, 80 and overBiological ProductsBiopsyDatabases, FactualDermatitis, Allergic ContactEczemaFemaleGlucocorticoidsHumansImmunosuppressive AgentsMaleMiddle AgedPredictive Value of TestsPsoriasisRemission InductionRetrospective StudiesSkinTreatment OutcomeYoung AdultConceptsAllergic contact dermatitisPsoriasis vulgarisClinical characteristicsHistopathological featuresEczematous changesDiagnostic workupSuccessful treatmentContact dermatitisOutcomes of patientsPercent of patientsHalf of patientsRetrospective chart reviewFeatures of psoriasisRetrospective clinicopathologic studyEczematous dermatosesEczematous featuresChart reviewClinicopathologic studyMost patientsSystemic therapyTopical glucocorticoidsHistopathologic featuresChallenging diagnosisClinicopathologic correlationTreatment modalitiesPsoriasis and COVID-19: a multifactorial consideration
Cohen JM, Perez-Chada LM, De Kouchkovsky D, Gehlhausen JR. Psoriasis and COVID-19: a multifactorial consideration. Journal Of Dermatological Treatment 2020, 33: 1174-1174. PMID: 32568011, PMCID: PMC7771226, DOI: 10.1080/09546634.2020.1782818.Peer-Reviewed Original Research